Navamedic ASA: Notification of major shareholding and mandatory notification of trade

Oslo, 20 February 2023 – Ingerø Reiten Investment Company AS (“IRIC”), a company controlled by Narve Reiten and a close associate to the chairman Terje Bakken and board member Narve Reiten in Navamedic ASA (“Navamedic”), has today sold 597,424 shares in Navamedic at a price per share of NOK 37 for total gross proceeds of approximately NOK 22 million. The shares were sold to two Nordic institutional investors. The shares sold equals approximately 3.4 per cent of the share capital and votes in Navamedic, reducing IRIC's holding of shares and votes from 20.53% to 17.1%. IRIC has no other rights to shares in Navamedic.

Please see attached notification form for further details.

This disclosure is made pursuant to article 19 of the EU Market Abuse Regulation and sections 4-2 and  5-12 of the Norwegian Securities Trading Act.